1 min read

Maine Center for Cancer Medicine has announced that it now offers a simple blood test that helps physicians make more informed decisions about caring for patients with metastatic breast, colorectal and prostate cancer.

The test can provide valuable information about the progression of the disease as early as the first cycle of treatment. According to Maine Center for Cancer Medicine, it is the first private practice in New England to perform this complex test in its laboratory.

The CellSearch Circulating Tumor Cell Test is the only diagnostic platform intended to capture, identify and monitor circulating tumor cells in patients with metastatic cancer. This routine blood test is expected to become an important resource for ongoing patient management.

Founded in 1978, Maine Center for Cancer Medicine is a private group practice of 14 oncologists and hematologists. Offices are located in Scarborough, Biddeford, Brunswick and Sanford. For more information, visit www.mccm.org .

Comments are no longer available on this story